AKTX

Akari Therapeutics

19 hedge funds and large institutions have $51M invested in Akari Therapeutics in 2016 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 4 closing their positions.

Holders
19
Holders Change
-1
Holders Change %
-5%
% of All Funds
0.51%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
3
Increased
3
Reduced
5
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
DM
1
Deerfield Management
New York
$16.1M 1,150,700
VC
2
Vivo Capital
California
$7.39M 527,842 +527,842 New
BBA
3
Baker Bros. Advisors
New York
$5.54M 395,882
VMI
4
VHCP Management II
New York
$5.17M 369,490
FCMI
5
Foresite Capital Management III
California
$3.7M 263,921
QF
6
QVT Financial
New York
$3.21M 263,921
RCM
7
RA Capital Management
Massachusetts
$2.6M 257,721 -6,200 -2%
VM
8
VHCP Management
New York
$2.22M 158,352
BC
9
Boxer Capital
California
$1.96M 139,899
EC
10
EcoR1 Capital
California
$1.29M 92,303 -8,447 -8%
GTC
11
Ghost Tree Capital
New York
$653K 46,622 -494 -1%
SM
12
Sabby Management
Florida
$606K 40,705 +40,705 New
ACP
13
Acuta Capital Partners
California
$236K 18,250 +1,227 +7%
Deutsche Bank
14
Deutsche Bank
Germany
$235K 23,387 +3,600 +18%
DCM
15
DAFNA Capital Management
California
$66K 4,741 -3,600 -43%
UBS Group
16
UBS Group
Switzerland
$18K 1,754 +1,034 +144%
Morgan Stanley
17
Morgan Stanley
New York
$18K 1,768 +1,768 New
TI
18
Turner Investments
Pennsylvania
$4K 345 -31,929 -99%
NMC
19
NEA Management Company
Maryland
-121,970 Closed
Millennium Management
20
Millennium Management
New York
-51,221 Closed
Bank of America
21
Bank of America
North Carolina
-1,504 Closed
TRCT
22
Tower Research Capital (TRC)
New York
-510 Closed
AIG
23
American International Group
New York
$0 25